961.63MMarket Cap-288916P/E (TTM)
34.730High33.250Low448.87KVolume34.480Open34.540Pre Close15.36MTurnover1.67%Turnover RatioLossP/E (Static)27.74MShares34.73052wk High2.27P/B933.58MFloat Cap16.20052wk Low--Dividend TTM26.93MShs Float107.690Historical High--Div YieldTTM4.29%Amplitude9.260Historical Low34.213Avg Price1Lot Size
Castle Biosciences Stock Forum
New Data at ASTRO 2024 Shows Castle Biosciences’ DecisionDx®-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma | CSTL Stock News
loading...
loading...
Businesswire· 4 mins ago
No comment yet